Haibel, H <br/><br/>
Multicenter open-label study with infliximab in active ankylosing spondylitis over 28 weeks in daily practice.  [electronic resource] 

 -  Clinical and experimental rheumatology   
 - 247-52 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0392-856X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Activities of Daily Living<br/>Acute Disease<br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Antirheumatic Agents--administration & dosage<br/>Employment<br/>Female<br/>Health Status<br/>Humans<br/>Infliximab<br/>Male<br/>Middle Aged<br/>Private Practice<br/>Prospective Studies<br/>Quality of Life<br/>Spondylitis, Ankylosing--drug therapy<br/>Treatment Outcome